How should diabetic retinopathy surveillance be adjusted for patients starting GLP-1 agonists?
Community PollStarted
How often do you perform diabetic retinopathy surveillance in patients with severe non-proliferative diabetic retinopathy on GLP1 without DME?
46 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Ophthalmology · Stanford University School of Medicine
Answered on
As with traditional anti-hyperglycemic medications, GLP-1 agonists may cause transient worsening of diabetic retinopathy due to the initial rapid control of blood glucose. Therefore, if a patient has existing retinopathy and is about to start GLP-1 agonist therapy, I recommend closer monitoring.
For...
Join for free or sign in to see the full answer